Immunicon Corp - Current report filing (8-K)
21 March 2008 - 7:16AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): March 14,
2008
IMMUNICON CORPORATION
(Exact Name
of Registrant Specified in Charter)
|
|
|
|
|
Delaware
|
|
000-50677
|
|
23-2269490
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
3401 Masons Mill Road, Suite 100
Huntingdon Valley, Pennsylvania
|
|
19006
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code: (215) 830-0777
Not Applicable
(Former Name or
Former Address, if Changed Since Last Report)
Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (
see
General Instruction A.2. below):
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.02.
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
The Board of Directors (the Board) of Immunicon Corporation, a Delaware corporation (Immunicon), appointed Teresa O. Lipcsey as
its new principal accounting officer, effective as of March 14, 2008. Ms. Lipcsey assumed the role of principal accounting officer from James G. Murphy, whose resignation as Immunicons Senior Vice President, Finance and
Administration and Chief Financial Officer was effective as of March 14, 2008.
Ms. Lipcsey, 42, has served as Vice President and
Corporate Controller of Immunicon since January 2005. From December 2003 to January 2005, Ms. Lipcsey served as Executive Director and Controller of Immunicon. From May 1999 to December 2003, Ms. Lipcsey was Corporate Controller of
Integrated Circuit Systems, Inc., a formerly public semiconductor company that designed, developed and marketed silicon timing devices. Ms. Lipcsey holds a B.S. in Accounting and Finance from University of Maryland and is a certified public
accountant and a certified treasury professional.
Ms. Lipcseys current annual salary is $200,000 and she is eligible to
participate in the benefit plans generally offered to Immunicon officers and employees. In addition, Immunicon has agreed to provide Ms. Lipcsey with a severance package if she is terminated by Immunicon (and her performance prior to that
termination is satisfactory) consisting of a lump sum payment equal to nine (9) months of her base salary and continuation of certain benefits under Immunicons benefit plans for the one (1) month period following her termination. If
Ms. Lipcsey agrees to sign a waiver at her termination under those circumstances, Immunicon has also agreed to continue certain benefits under Immunicons benefit plans for a further two (2) month period in addition to the one
(1) month period described above.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, Immunicon has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
IMMUNICON CORPORATION
|
|
|
By:
|
|
/s/ BYRON D. HEWETT
|
|
|
Byron D. Hewett
|
|
|
President and Chief Executive Officer
|
Dated: March 20, 2008
Immunicon (NASDAQ:IMMC)
Historical Stock Chart
From May 2024 to Jun 2024
Immunicon (NASDAQ:IMMC)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Immunicon (MM) (NASDAQ): 0 recent articles
More Immunicon Corp News Articles